Listen

Goals

  • To identify novel host defects that predispose individuals to fungal diseases and elucidating their mechanisms of pathogenicity to inform targeted therapeutic approaches. 
  • To develop innovative diagnostics and therapeutic strategies. 
  • To enhance global surveillance systems for emerging fungal diseases and antifungal drug resistance. 
  • To strengthen interdisciplinary collaborations to address critical gaps in fungal disease research. 


go to main content
Research Research programs Fungal disease

Our mission

We aim to advance our understanding, prevention and treatment of fungal diseases that impact human health globally.

Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Antifungal pharmacology

Roger Brüggemann's research group aims to develop innovative and personalized antimicrobial pharmacological approaches in order to reduce infectious disease related morbidity and mortality.

Clinical mycology

Paul Verweij's research group investigates how aspergillus, a fungus that causes life-threatening infections in immunocompromised and ICU patients, develops resistance.

Experimental internal medicine

Mihai Netea's research group investigates the regulation of innate immune responses in health and disease, and based on that it designs and tests new approaches of immunotherapy in infections and immune-mediated diseases.

Spokesperson

prof. dr. Roger Brüggemann

contact form